FDA Clearance Tracker · DEN190037
NaviCam Capsule Endoscope System with NaviCam Stomach Capsule
Last checked: Nov 19, 2026Latest source record: May 22, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 22, 2020
De Novo granted
Time to decision
283 days
Received Aug 13, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN190037
- Device name
- NaviCam Capsule Endoscope System with NaviCam Stomach Capsule
- Applicant
- Anx Robotica, Inc.
- Applicant location
- Dover, DE
- Received
- Aug 13, 2019
- Decided
- May 22, 2020
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1310
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN190037
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Anx Robotica, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.